ftInvstr
BALAXI · Healthcare ₹22.77 +1.92% Mkt Cap ₹126 Cr

BALAXI

Healthcare Drug Manufacturers - Specialty & Generic
₹22.77
+1.92% today · 30d +1.92%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for BALAXI. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2025-12-31
REVENUE
₹73 Cr
-1.02% YoY
NET PROFIT
₹0 Cr
-94.31% YoY
OPM
4.38%
-5.88pp YoY
EPS
₹0.06
PE 50.38
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-28.9% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
BALAXI50.3813.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
43
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation STRETCHED 20
Growth STEADY 68
Profitability AVERAGE 45
Technicals WEAK 40
Risk LOW 80
Key Stats
TTM PE
50.38
P/B
0.5
52W HIGH
₹43.85
OFF HIGH
-48.07%
DIV YIELD
0.0%
MKT CAP
₹126 Cr
◉ Active Signals
MACDNeutral0.3546
RSI(14)Bullish60.65
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold BALAXI and at what entry.

Sign up freeSign in